![Thomas Bumol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Bumol
Direttore/Membro del Consiglio presso
OMEROS CORPORATION
Patrimonio netto: 95 100 $ in data 30/06/2026
Profilo
Thomas F.
Bumol is currently an Independent Director at Omeros Corp.
since 2019, a Director at Revalesio Corp.
since 2020, a Director at Spine BioPharma, Inc., an Independent Director at Tentarix Biotherapeutics LP since 2022, and a Venture Partner at Samsara BioCapital LLC starting in 2026.
Formerly, Dr. Bumol was a Director at PanTheryx, Inc., Executive Director & Executive Vice President at Allen Institute For Immunology from 2018 to 2022, Senior VP-Biotechnology & Autoimmunity Research at Eli Lilly & Co. from 2015 to 2017, President at Applied Molecular Evolution, Inc., and Vice President-Research Technologies & Proteins at Lilly Research Laboratories from 2001 to 2012.
Education includes an undergraduate degree from the University of Michigan in 1975 and a doctorate from the University of Minnesota in 1980.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
OMEROS CORPORATION 0,01% | 18/06/2026 | 10.000 ( 0,01% ) | 95 100 $ | 30/06/2026 |
Posizioni attive di Thomas Bumol
| Società | Posizione | Inizio |
|---|---|---|
| OMEROS CORPORATION | Direttore/Membro del Consiglio | 09/02/2019 |
Revalesio Corp.
 Revalesio Corp. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for the treatment of inflammatory diseases | Direttore/Membro del Consiglio | 01/10/2020 |
Tentarix Biotherapeutics LP
 Tentarix Biotherapeutics LP BiotechnologyHealth Technology Operates as a biotechnology company | Direttore/Membro del Consiglio | 20/05/2022 |
Spine BioPharma LLC
 Spine BioPharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Direttore/Membro del Consiglio | - |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Investitore di Private Equity | 01/01/2026 |
Precedenti posizioni note di Thomas Bumol
| Società | Posizione | Fine |
|---|---|---|
Allen Institute For Immunology
 Allen Institute For Immunology Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit bioscience research institute | Direttore/Membro del Consiglio | 01/08/2022 |
| ELI LILLY AND COMPANY | Direttore Tecnico/Scientifico/R&S | 01/12/2017 |
PanTheryx, Inc.
 PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional supplements | Direttore/Membro del Consiglio | - |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Engages in research and develops medicines | Direttore Tecnico/Scientifico/R&S | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Formazione di Thomas Bumol
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
83
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Applied Molecular Evolution, Inc.
 Applied Molecular Evolution, Inc. BiotechnologyHealth Technology Develops and manufactures proteins & genes for commercial purposes | Health Technology |
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
PanTheryx, Inc.
PanTheryx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional supplements | Health Technology |
Revalesio Corp.
Revalesio Corp. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for the treatment of inflammatory diseases | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Engages in research and develops medicines | Commercial Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Allen Institute For Immunology
Allen Institute For Immunology Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit bioscience research institute | Commercial Services |
Spine BioPharma LLC
Spine BioPharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Tentarix Biotherapeutics LP
Tentarix Biotherapeutics LP BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
